This is a synthetic peptide designed for use in combination with anti-LIG1 Antibody(ARP54308_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
LIG1
(Ligase I, DNA, ATP-Dependent (LIG1))
Synonyme
ATLIG1 Peptide, DNA ligase 1 Peptide, T6D22.23 Peptide, ligI Peptide, AL033288 Peptide, LigI Peptide, lig1 Peptide, wu:fc54a11 Peptide, DNA ligase 1 Peptide, DNA ligase 1, putative Peptide, ligase I, DNA, ATP-dependent L homeolog Peptide, ligase I, DNA, ATP-dependent Peptide, LIG1 Peptide, PB000674.02.0 Peptide, PTRG_06243 Peptide, PKH_140260 Peptide, lig1.L Peptide, Lig1 Peptide, lig-1 Peptide, lig1 Peptide
Hintergrund
LIG1is DNA ligase I, with functions in DNA replication and the base excision repair process. Mutations in LIG1 that lead to DNA ligase I deficiency result in immunodeficiency and increased sensitivity to DNA-damaging agents.
Alias Symbols: MGC117397, MGC130025
Protein Interaction Partner: PCNA,CSNK2A1,INPP1,MRE11A,PCNA,TUBB3,MRE11A,PCNA,UBC